Institutional investors purchased a net $454.2 thousand shares of NLNK during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 48.96% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 492.3 Thousand shares of NewLink Genetics Corp